Effects of thyroxin and donepezil on hippocampal acetylcholine content and syntaxin‑1 and munc‑18 expression in adult rats with hypothyroidism

Wang,Nan; Cai,Yaojun; Wang,Fen; Zeng,Xianzhong; Jia,Xuemei; Tao,Fangbiao; Zhu,Defa

doi:10.3892/etm.2014.1487

Effects of thyroxin and donepezil on hippocampal acetylcholine content and syntaxin‑1 and munc‑18 expression in adult rats with hypothyroidism

Authors:
- Nan Wang
- Yaojun Cai
- Fen Wang
- Xianzhong Zeng
- Xuemei Jia
- Fangbiao Tao
- Defa Zhu
View Affiliations

Affiliations: Department of Endocrinology, Anhui Geriatric Institute, The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui 230022, P.R. China, Comprehensive Laboratory, College of Basic Medicine, Anhui Medical University, Hefei, Anhui 230032, P.R. China, College of Public Hygiene, Anhui Medical University, Hefei, Anhui 230032, P.R. China
Published online on: January 16, 2014 https://doi.org/10.3892/etm.2014.1487
Pages: 529-536

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Adult‑onset hypothyroidism induces various impairments in hippocampus‑dependent cognitive function, in which numerous synaptic proteins and neurotransmitters are involved. Donepezil (DON), an acetylcholinesterase inhibitor, has been shown to be efficient in improving cognitive function. The aim of the present study was to investigate the effects of adult‑onset hypothyroidism on the expression levels of the synaptic proteins syntaxin‑1 and munc‑18, as well as the content of the neurotransmitter acetylcholine (ACh) in the hippocampus. In addition, the study explored the effects of thyroxin (T4) and DON treatment on the altered parameters. The study involved 55 Sprague‑Dawley rats that were randomly divided into five groups: Control, hypothyroid (0.05% 6‑n‑propyl‑2‑thiouracil; added to the drinking water), hypothyroid treated with T4 (6 µg/100 g body weight once daily; intraperitoneal injection), hypothyroid treated with DON (0.005%; added to the drinking water) and hypothyroid treated with a combination of the two drugs (6 µg/100 g T4 and 0.005% DON). The concentration of ACh was determined in the homogenized hippocampus of each animal by alkaline hydroxylamine colorimetry. The protein levels of syntaxin‑1 and munc‑18 were determined by immunohistochemistry. The results showed that the content of ACh in the hippocampi of the hypothyroid rats was significantly decreased compared with that in the controls and that T4 monotherapy and DON administration restored the ACh content to normal values. In the hippocampi of the hypothyroid group, munc‑18 was expressed at significantly lower levels, while the expression levels of syntaxin‑1 were increased compared with the levels in the control group. Treatment with T4 alone restored the expression of syntaxin‑1 but failed to normalize munc‑18 expression levels. The co‑administration of T4 and DON returned the munc‑18 levels to normal values. These observations indicate that adult‑onset hypothyroidism induces alterations in the levels of munc‑18, syntaxin‑1 and ACh in the hippocampus. Syntaxin‑1 and ACh levels were restored by T4 monotherapy while munc‑18 levels were not. In addition, the co‑administration of T4 and DON resulted in more effective restoration than either alone. The thyroid hormone has a direct effect on metabolism of hippocampal ACh in adult rats and DON is helpful for treatment of synaptic protein impairment induced by hypothyroidism.

View Figures

View References

1	Alzoubi KH, Gerges NZ, Aleisa AM and Alkadhi KA: Levothyroxin restores hypothyroidism-induced impairment of hippocampus-dependent learning and memory: Behavioral, electrophysiological, and molecular studies. Hippocampus. 19:66–78. 2009. View Article : Google Scholar
2	Smith JW, Evans AT, Costall B and Smythe JW: Thyroid hormones, brain function and cognition: a brief review. Neurosci Biobehav Rev. 26:45–60. 2002. View Article : Google Scholar : PubMed/NCBI
3	Liu CL, Xu YX, Zhan Y, et al: Effect of thyroxine on synaptotagmin 1 and SNAP-25 expression in dorsal hippocampus of adult-onset hypothyroid rats. J Endocrinol Invest. 34:280–286. 2011. View Article : Google Scholar : PubMed/NCBI
4	Zhu DF, Wang ZX, Zhang DR, et al: fMRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism. Brain. 129:2923–2930. 2006. View Article : Google Scholar : PubMed/NCBI
5	Weimer RM, Richmond JE, Davis WS, Hadwiger G, Nonet ML and Jorgensen EM: Defects in synaptic vesicle docking in unc-18 mutants. Nat Neurosci. 6:1023–1030. 2003. View Article : Google Scholar : PubMed/NCBI
6	Shen J, Tareste DC, Paumet F, Rothman JE and Melia TJ: Selective activation of cognate SNAREpins by Sec1/Munc18 proteins. Cell. 128:183–195. 2007. View Article : Google Scholar : PubMed/NCBI
7	Gengyo-Ando K, Kitayama H, Mukaida M and Ikawa Y: A murine neural-specific homolog corrects cholinergic defects in Caenorhabditis elegans unc-18 mutants. J Neurosci. 16:6695–6702. 1996.PubMed/NCBI
8	Sakisaka T, Yamamoto Y, Mochida S, et al: Dual inhibition of SNARE complex formation by tomosyn ensures controlled neurotransmitter release. J Cell Biol. 183:323–337. 2008. View Article : Google Scholar : PubMed/NCBI
9	de Wit H, Cornelisse LN, Toonen RF and Verhage M: Docking of secretory vesicles is syntaxin dependent. PLoS One. 1:e1262006.PubMed/NCBI
10	Han GA, Malintan NT, Collins BM, Meunier FA and Sugita S: Munc18–1 as a key regulator of neurosecretion. J Neurochem. 115:1–10. 2010.
11	Alzoubi KH, Gerges NZ and Alkadhi KA: Levothyroxin restores hypothyroidism-induced impairment of LTP of hippocampal CA1: electrophysiological and molecular studies. Exp Neurol. 195:330–341. 2005. View Article : Google Scholar : PubMed/NCBI
12	Leentjens AF and Kappers EJ: Persistent cognitive defects after corrected hypothyroidism. Psychopathology. 28:235–237. 1995. View Article : Google Scholar : PubMed/NCBI
13	Zhu Y, Ning D, Wang F, Liu C, Xu Y, Jia X and Zhu D: Effect of thyroxine on munc-18 and syntaxin-1 expression in dorsal hippocampus of adult-onset hypothyroid rats. Eur J Histochem. 56:e222012. View Article : Google Scholar : PubMed/NCBI
14	Vallortigara J, Alfos S, Micheau J, Higueret P and Enderlin V: T3 administration in adult hypothyroid mice modulates expression of proteins involved in striatal synaptic plasticity and improves motor behavior. Neurobiol Dis. 31:378–385. 2008. View Article : Google Scholar : PubMed/NCBI
15	Akasofu S, Kimura M, Kosasa T, Sawada K and Ogura H: Study of neuroprotection of donepezil, a therapy for Alzheimer’s disease. Chem Biol Interact. 175:222–226. 2008.
16	Giacobini E: Cholinesterase inhibitors stabilize Alzheimer’s disease. Ann NY Acad Sci. 920:321–327. 2000.
17	Nordberg A and Svensson AL: Cholinesterase inhibitors in the treatment of Alzheimer’s disease: a comparison of tolerability and pharmacology. Drug Saf. 19:465–480. 1998.
18	Hestrin S: The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application. J Biol Chem. 180:249–261. 1949.PubMed/NCBI
19	Sokoloff L and Klee CB: The effect of thyroid on protein synthesis in brain and other organs. Res Publ Assoc Res Nerv Ment Dis. 43:371–386. 1966.PubMed/NCBI
20	Hepp R, Grant NJ, Chasserot-Golaz S, Aunis D and Langley K: The hypophysis controls expression of SNAP-25 and other SNAREs in the adrenal gland. J Neurocytol. 30:789–800. 2001. View Article : Google Scholar : PubMed/NCBI
21	Quintanar JL and Salinas E: Effect of hypothyroidism on synaptosomal-associated protein of 25 kDa and syntaxin-1 expression in adenohypophyses of rat. J Endocrinol Invest. 25:754–758. 2002. View Article : Google Scholar : PubMed/NCBI
22	Yang HY, Sun CP, Jia XM, Gui L, Zhu DF and Ma WQ: Effect of thyroxine on SNARE complex and synaptotagmin-1 expression in the prefrontal cortex of rats with adult-onset hypothyroidism. J Endocrinol Invest. 35:312–316. 2012.PubMed/NCBI
23	Broedel O, Eravci M, Fuxius S, Smolarz T, Jeitner A, Grau H, et al: Effects of hyper- and hypothyroidism on thyroid hormone concentrations in regions of the rat brain. Am J Physiol Endocrinol Metab. 285:E470–E480. 2003.PubMed/NCBI
24	Constantinou C, Margarity M and Valcana T: Region-specific effects of hypothyroidism on the relative expression of thyroid hormone receptors in adult rat brain. Mol Cell Biochem. 278:93–100. 2005. View Article : Google Scholar : PubMed/NCBI
25	Molinengo L, Cassone MC and Oggero L: Action of hypo- and hyperthyroidism on the postmortal decay of acetylcholine in the rat spinal cord. Neuroendocrinology. 42:28–31. 1986. View Article : Google Scholar : PubMed/NCBI
26	Gould E and Butcher LL: Developing cholinergic basal forebrain neurons are sensitive to thyroid hormone. J Neurosci. 9:3347–3358. 1989.PubMed/NCBI
27	Ahmed MT, Sinha AK, Pickard MR, Kim KD and Ekins RP: Hypothyroidism in the adult rat causes brain region-specific biochemical dysfunction. J Endocrinol. 138:299–305. 1993. View Article : Google Scholar : PubMed/NCBI
28	Mehndiratta MM, Pandey S and Kuntzer T: Acetylcholinesterase inhibitor treatment for myasthenia gravis. Cochrane Database Syst Rev. 2:CD0069862011.
29	Kroker KS, Rast G, Giovannini R, Marti A, Dorner-Ciossek C and Rosenbrock H: Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP. Neuropharmacology. 62:1964–1974. 2012. View Article : Google Scholar : PubMed/NCBI
30	Barnes CA, Meltzer J, Houston F, Orr G, McGann K and Wenk GL: Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors. Neuroscience. 99:17–23. 2000. View Article : Google Scholar : PubMed/NCBI
31	Shahrara S, Drvota V and Sylvén C: Organ specific expression of thyroid hormone receptor mRNA and protein in different human tissues. Biol Pharm Bull. 22:1027–1033. 1999. View Article : Google Scholar : PubMed/NCBI
32	Ladinsky H, Consolo S, Peri G and Garattini S: Acetylcholine, choline and choline acetyltransferase activity in the developing brain of normal and hypothyroid rats. J Neurochem. 19:1947–1952. 1972. View Article : Google Scholar : PubMed/NCBI
33	Wekking EM, Appelhof BC, Fliers E, et al: Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol. 153:747–753. 2005. View Article : Google Scholar : PubMed/NCBI
34	de Wit H, Walter AM, Milosevic I, Gulyás-Kovács A, Riedel D, Sørensen JB and Verhage M: Synaptotagmin-1 docks secretory vesicles to syntaxin-1/SNAP-25 acceptor complexes. Cell. 138:935–946. 2009.PubMed/NCBI
35	van Doorn J, Roelfsema F and van der Heide D: Concentrations of thyroxine and 3,5,3′-triiodothyronine at 34 different sites in euthyroid rats as determined by an isotopic equilibrium technique. Endocrinology. 117:1201–1208. 1985.
36	Dong H, Yuede CM, Coughlan CA, Murphy KM and Csernansky JG: Effects of donepezil on amyloid-beta and synapse density in the Tg2576 mouse model of Alzheimer’s disease. Brain Res. 1303:169–178. 2009.PubMed/NCBI
37	Mori E, Hashimoto M, Krishnan KR and Doraiswamy PM: What constitutes clinical evidence for neuroprotection in Alzheimer disease: support for the cholinesterase inhibitors. Alzheimer Dis Assoc Disord. 20(2 Suppl 1): S19–S26. 2006. View Article : Google Scholar : PubMed/NCBI
38	Riepe MW: Cholinergic treatment: what are the early neuropathological targets. Eur J Neurol. 12:3–9. 2005. View Article : Google Scholar : PubMed/NCBI
39	Alcántara-González F, Mendoza-Perez CR, Zaragoza N, et al: Combined administration of cerebrolysin and donepezil induces plastic changes in prefrontal cortex in aged mice. Synapse. 66:938–949. 2012.PubMed/NCBI
40	Yoshiyama Y, Kojima A, Ishikawa C and Arai K: Anti-inflammatory action of donepezil ameliorates tau pathology, synaptic loss, and neurodegeneration in a tauopathy mouse model. J Alzheimers Dis. 22:295–306. 2010.PubMed/NCBI
41	Autio H, Mätlik K, Rantamäki T, et al: Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus. Neuropharmacology. 61:1291–1296. 2011. View Article : Google Scholar : PubMed/NCBI
42	Shen H, Kihara T, Hongo H, et al: Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of alpha7 nicotinic receptors and internalization of NMDA receptors. Br J Pharmacol. 161:127–139. 2010. View Article : Google Scholar